Enchem (A348370) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Apr, 2026Executive summary
Revenue for FY2023 was ₩424.7 billion, down 16.6% year-over-year, with operating income dropping 66.6% to ₩5.1 billion and a net loss of ₩49.2 billion, reversing a prior year profit.
The company’s core business is the manufacture and sale of electrolyte solutions for secondary batteries, with global operations and major customers in the battery and automotive sectors.
Significant investments were made in overseas plant expansions and new business areas, including NMP recycling and joint ventures for raw material supply.
Financial highlights
Total assets increased 30.3% year-over-year to ₩886.9 billion, while total liabilities rose 54.2% to ₩596.8 billion.
Cash and cash equivalents at year-end were ₩45.7 billion, up from ₩33.3 billion the previous year.
Gross margin remained stable at ₩50.1 billion, but operating margin contracted sharply due to higher SG&A and financial costs.
Major financial activities included issuance of convertible bonds and rights offering, with significant capital expenditures for capacity expansion.
Outlook and guidance
The company expects continued growth in the global EV and battery markets, with further expansion of overseas production capacity and new business lines.
Management is focused on strengthening supply chain stability and cost competitiveness through vertical integration and recycling initiatives.
Latest events from Enchem
- Significant net loss in H1 2024 despite strong liquidity and new global subsidiaries.A348370
Q2 202420 Feb 2026 - Significant net loss and revenue decline, but liquidity and capital resources remain strong.A348370
Q3 202420 Feb 2026 - 2024 saw a steep revenue drop, heavy net loss, and major impairments amid persistent market risks.A348370
Q4 202420 Feb 2026 - Net income swung to ₩58.2B on ₩68.2B sales, with major post-quarter asset acquisitions.A348370
Q1 202520 Feb 2026 - Revenue fell and operating loss was recorded, but net income rebounded sharply.A348370
Q2 202520 Feb 2026 - Revenue fell and operating loss widened, but net loss improved; liquidity remains solid.A348370
Q3 202520 Feb 2026